BioApp
Latest round
- Series C
Last raised
- Mar 2020
Total raised
- $15M
Investors
- 6
About BioApp
, trading under the name BioApp, operates as a vaccine development company. BioApp provides vaccinations for both human and animal diseases, including the COVID-19 and swine fever vaccines. The company also provides Green Vaccine, a vaccine made from plant proteins extracted and refined using plant protein platform technology.
Who invested in BioApp
6 investors across 3 rounds
See all investors in BioApp
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioApp
Who invested in BioApp?
BioApp has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioApp raised?
BioApp has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BioApp last raise money?
BioApp's most recent round on record is a Series C, in Mar 2020.
What does BioApp do?
, trading under the name BioApp, operates as a vaccine development company.
Where is BioApp headquartered?
BioApp is headquartered in Gyeongsangbuk-do, South Korea.
Which VCs invest in companies like BioApp?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at BioApp's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like BioApp? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.